Home | Coverage | Agents | Pulse | LogIn |
| Darwin Score | +7 |
| Ticker | TLX |
| Latest Price | 24.19 AUD as of close on 04-Jul-2025 |
| 3 Month price range | 23.15 to 29.32 AUD |
| Market Capitalisation | 8.04Bn AUD |
| Country | Australia |
| Region | Asia |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Biotechnology |
| Sub-Industry | Biotechnology |
| Description | Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals for cancer and rare diseases in Australia, Belgium, Japan, Switzerland, and the United States. The company offers Illuccix for the treatment of prostate cancer; and TLX66-CDx for the treatment of imaging osteomyelitis. Its products candidates include TLX591, a radio antibody-drug conjugate for the treatment of prostate cancer; TLX250-CDx for the treatment and diagnosis of renal (kidney) cancer; TLX101-CDx for brain (glioma) cancer; TLX66-CDx to treat bone marrow conditioning; TLX300-CDx for the treatment and diagnosis of soft tissue sarcoma; and TLX250 for the treatment of clear cell renal cell carcinoma. The company also develops TLX101 for the treatment of glioblastoma (brain cancer); TLX66 for the treatment of bone marrow conditioning; TLX300 for the treatment of soft tissue sarcoma; and TLX592, a prostate cancer therapy candidate for targeted alpha therapy. Telix Pharmaceuticals Limited was founded in 2015 and is headquartered in North Melbourne, Australia. See More ... |
| Company URL | https://telixpharma.com |
| See Darwins Full Analysis for Telix Pharmaceuticals Ltd |
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Telix Pharmaceuticals Ltd. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | -8 |
| Sentiment | News and Candle Patterns. | 0 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | -1 |
| Flow | Institutional, Fund and Insider buying and selling. | 0 |
| Models | Forecast models. | +16 |
There are 3 live alerts for Telix Pharmaceuticals Ltd.
There are 12 peers of Telix Pharmaceuticals Ltd.
| Asset Name | Industry Group | Perf(20d)% | Asset Score |
|---|---|---|---|
| Argenica Therapeutics Ltd (AGN) | Biotechnology | -2.0 | +22 |
| Arovella Therapeutics Ltd (ALA) | Biotechnology | +19.2 | +2 |
| CSL Ltd (CSL) | Biotechnology | -2.1 | +19 |
| Clinuvel Pharmaceuticals Ltd (CUV) | Biotechnology | -1.9 | +7 |
| Imugene Ltd (IMU) | Biotechnology | -23.7 | -9 |
| Mesoblast Ltd (MSB) | Biotechnology | -7.9 | -10 |
| Opthea Ltd (OPT) | Biotechnology | 0 | -12 |
| PYC Therapeutics Ltd (PYC) | Biotechnology | +9.1 | +24 |
| Paradigm Biopharmaceuticals Ltd (PAR) | Biotechnology | +49.2 | +18 |
| Polynovo Ltd (PNV) | Biotechnology | -9.1 | +2 |
| Race Oncology Ltd (RAC) | Biotechnology | -0.4 | -9 |
| Tissue Repair Ltd (TRP) | Biotechnology | +16.2 | -10 |
To see complete information on Telix Pharmaceuticals Ltd or any other assets please login.
If you do not already have an account you can register for a free trial of our service. This will let you explore all the analytical information we have on price, fundamantals, flow, sentiments & models for all the stocks under coverage. You will then be able to compare asset scores and perform a wide range of multi asset analysis such as Market Cycles and Relative Scores.
Follow Us | |
©2025 Darwin Knows - All Rights Reserved | |